Rigetti Computing (RGTI) Is Down 8.3% After India Quantum Deal And Wider Q4 Losses Has The Bull Case Changed?

Rigetti Computing, Inc. -3.44%

Rigetti Computing, Inc.

RGTI

14.88

-3.44%

  • Rigetti Computing recently reported fourth-quarter 2025 results, with sales of US$1.87 million and a net loss of US$18.21 million, while reaffirming plans to deploy a 108-qubit system backed by an US$8.4 million contract with India’s Centre for Development of Advanced Computing.
  • Beyond the headline contract, Rigetti’s push into chiplet-based modular quantum processors and improving gate fidelities suggests a focus on making its 108-qubit hardware more practically useful for research and government customers.
  • Next, we’ll examine how the US$8.4 million Indian quantum contract could reshape Rigetti’s investment narrative and growth expectations.

This technology could replace computers: discover 24 stocks that are working to make quantum computing a reality.

Rigetti Computing Investment Narrative Recap

To own Rigetti today, you have to believe that its superconducting, chiplet based quantum hardware can convert technical milestones into a larger base of paying users before cash burn and losses become too heavy. The key near term catalyst is still successful deployment and performance of the 108 qubit system, and the latest results plus the India contract reaffirm that timeline. The biggest risk remains continued high losses relative to very small revenue.

The US$8.4 million contract with India’s Centre for Development of Advanced Computing is the clearest link between Rigetti’s 108 qubit roadmap and future revenue potential, since it ties a specific system to a defined customer and deployment date. Compared with earlier contracts, it directly reinforces the idea that higher qubit counts and better fidelities can support more substantial on premises system sales if Rigetti executes on delivery.

Yet, despite this progress, investors should be aware that Rigetti’s reliance on lumpy government and research contracts could still...

Rigetti Computing's narrative projects $78.2 million revenue and $11.1 million earnings by 2029. This requires 118.6% yearly revenue growth and a $362.1 million earnings increase from $-351.0 million today.

Uncover how Rigetti Computing's forecasts yield a $38.40 fair value, a 138% upside to its current price.

Exploring Other Perspectives

RGTI 1-Year Stock Price Chart
RGTI 1-Year Stock Price Chart

Some of the most optimistic analysts were penciling in revenue growth of about 165 percent a year and positive earnings by 2028, which is far more bullish than cautious views that stress ongoing dependence on government funding cycles and execution risk on the 108 qubit roadmap; with this new contract and earnings update, you can judge for yourself whether those earlier, very ambitious forecasts still feel realistic or might need to be revisited.

Explore 40 other fair value estimates on Rigetti Computing - why the stock might be worth over 2x more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Rigetti Computing research is our analysis highlighting 1 key reward and 4 important warning signs that could impact your investment decision.
  • Our free Rigetti Computing research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Rigetti Computing's overall financial health at a glance.

Ready For A Different Approach?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

  • The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 21 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
  • Find 47 companies with promising cash flow potential yet trading below their fair value.
  • AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via